Solitary Primary Tracheal Small-Cell Lung Cancer Causing Acute Respiratory Failure: Diagnosis and Treatment

Chou-Chin Lan; Mei-Chen Yang; Chih-Hsin Lee; Shiu-Feng Huang; Yao-Kuang Wu
July 2010
Respiratory Care;Jul2010, Vol. 55 Issue 7, p929
Academic Journal
Case Study
Small-cell lung cancer often presents as an extensive cancer, and rarely as a solitary tracheal tumor. We report a 41-year-old male smoker with dyspnea and wheezing that was initially diagnosed as asthma and treated with bronchodilators. He was later intubated for acute respiratory failure, and computed tomography revealed a tracheal mass. Solitary primary small-cell lung cancer was diagnosed via bronchoscopic biopsy. The patient received bronchoscopic electro-surgery and was successfully extubated. Concurrent chemo-radiotherapy was performed due to the stage IV smallcell lung cancer.


Related Articles

  • Sigara İçenlerde ve İçmeyenlerde AkciÄŸer Kanseri: Genel Özelliklerde Farklılık Var mı? Erbaycu, Ahmet E.; Uslu, Özgür; Tuksavul, Fevziye; Gülpek, Mehmet; Gürsoy, Soner; Delıbaş, Mustafa; Güçlü, Salih Z. // International Journal of Hematology & Oncology / UHOD: Uluslarar;Jun2009, Vol. 19 Issue 2, p95 

    Lung cancer occurs usually in smokers, but may occur in non-smoker by various factors. It was evaluated that if general characteristics differ in smoker and non-smoker lung cancer patients or not. Patients diagnosed between 1999-2008 were assessed with gender, age, cigarette smoking, tumor cell...

  • Stereotactic ablative radiotherapy recommended for NSCLC patients at high risk for surgical complications.  // Hem/Onc Today;9/10/2012, Vol. 13 Issue 17, p41 

    The article discusses research by David Palma and colleagues of the London Regional Cancer Program in Ontario which suggests that patients with early-stage non-small cell lung cancer who are at high risk for surgical complications should be recommended for stereotactic ablative radiation therapy...

  • Prophylactic cranial irradiation for patients with small-cell lung cancer. Bunn Jr., Paul A.; Kelly, Karen // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p161 

    Editorial. Comments on prophylactic cranial irradiation for patients with small cell lung cancer. Histological differentiation between small cell lung cancer and non-small cell lung cancer; Reduction of central nervous system metastases rate with prophylactic irradiation; Stratification of...

  • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Arriagada, Rodrigo; Le Chevalier, Thierry // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p183 

    Evaluates the effects of prophylactic cranial irradiation on brain metastasis, overall survival and late-occurring toxic effects in patients with small-cell lung cancer in complete remission. Decrease in risk of brain metastasis; Possible beneficial effect on overall survival; Trial design;...

  • Prognostic factors identified for locally advanced NSCLC. Fisher, Stacey L.; Sharer, Emily; Volansky, Rob // Hem/Onc Today;2/25/2011, Vol. 12 Issue 4, p26 

    The article discusses research conducted by B. Jeremic and colleagues which focused on the identification of prognostic factors in patients with stage III non-small cell lung cancer who were treated with hyperfractionated radiation therapy.

  • Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer: excellent tolerance using subcutaneous amifostine for cytoprotection. Koukourakis, M.I.; Romanidis, K.; Froudarakis, M.; Kyrgias, G.; Koukourakis, G.V.; Retalis, G.; Bahlitzanakis, N. // British Journal of Cancer;8/12/2002, Vol. 87 Issue 4, p385 

    The substantial augmentation of the radiation sequelae during chemo-radiotherapy with novel drugs masks the real potential of such regimens. In this study we examined whether subcutaneous administration of amifostine can reduce the toxicity of a highly aggressive chemo-radiotherapy scheme with...

  • POINT / COUNTER. Bin Teh; Loo Jr., Billy W. // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p11 

    The article presents two different views on which is the better option for treating small cell lung cancer (SCLC), the high-dose thoracic radiation therapy with 60 Gy to 70 Gy or the standard of care.

  • Lack of initial response to chemoradiotherapy linked to poorer outcome.  // Hem/Onc Today;9/10/2012, Vol. 13 Issue 17, p39 

    The article discusses research which reveals that patients with small cell lung cancer who failed to achieve complete/partial response following their first course of platin-based chemoradiotherapy suffered a poorer outcome, despite getting an objective response throughout the treatment course.

  • Surgery in limited-disease small-cell lung cancer. Koul, Parvaiz A. // Lung India;Jan-Mar2012, Vol. 29 Issue 1, p2 

    The author reflects on the abandonment of surgery as a treatment of choice for patients with limited-disease small-cell lung cancer (LD-SCLC) due to the result of a randomized trial which revealed a survival difference between surgery and radiotherapy. An overview of some studies which show that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics